HEADER HYDROLASE/HYDROLASE INHIBITOR 27-AUG-15 5DGJ TITLE 1.0A RESOLUTION STRUCTURE OF NOROVIRUS 3CL PROTEASE IN COMPLEX AN TITLE 2 OXADIAZOLE-BASED, CELL PERMEABLE MACROCYCLIC (20-MER) INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 1101-1281; COMPND 5 EC: 3.4.22.66; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: NORWALK VIRUS; SOURCE 3 ORGANISM_COMMON: HU/NV/NV/1968/US; SOURCE 4 ORGANISM_TAXID: 524364; SOURCE 5 STRAIN: GI/HUMAN/UNITED STATES/NORWALK/1968; SOURCE 6 GENE: ORF1; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS PROTEASE, NOROVIRUS, NORWALK VIRUS, ANTIVIRAL INHIBITORS, OXADIAZOLE KEYWDS 2 INHIBITOR, CELL PERMEABLE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.LOVELL,K.P.BATTAILE,N.MEHZABEEN,V.C.DAMALANKA,Y.KIM,K.R.ALLISTON, AUTHOR 2 P.M.WEERAWARNA,A.C.G.KANKANAMALAGE,G.H.LUSHINGTON,K.-O.CHANG, AUTHOR 3 W.C.GROUTAS REVDAT 7 27-SEP-23 5DGJ 1 REMARK REVDAT 6 12-AUG-20 5DGJ 1 REMARK REVDAT 5 11-DEC-19 5DGJ 1 REMARK REVDAT 4 27-SEP-17 5DGJ 1 JRNL REMARK REVDAT 3 23-MAR-16 5DGJ 1 JRNL REVDAT 2 17-FEB-16 5DGJ 1 JRNL REVDAT 1 10-FEB-16 5DGJ 0 JRNL AUTH V.C.DAMALANKA,Y.KIM,K.R.ALLISTON,P.M.WEERAWARNA, JRNL AUTH 2 A.C.GALASITI KANKANAMALAGE,G.H.LUSHINGTON,N.MEHZABEEN, JRNL AUTH 3 K.P.BATTAILE,S.LOVELL,K.O.CHANG,W.C.GROUTAS JRNL TITL OXADIAZOLE-BASED CELL PERMEABLE MACROCYCLIC TRANSITION STATE JRNL TITL 2 INHIBITORS OF NOROVIRUS 3CL PROTEASE. JRNL REF J.MED.CHEM. V. 59 1899 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 26823007 JRNL DOI 10.1021/ACS.JMEDCHEM.5B01464 REMARK 2 REMARK 2 RESOLUTION. 1.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.20 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.060 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 82775 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.143 REMARK 3 R VALUE (WORKING SET) : 0.143 REMARK 3 FREE R VALUE : 0.154 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.820 REMARK 3 FREE R VALUE TEST SET COUNT : 3986 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 32.2184 - 3.0358 1.00 2913 169 0.1602 0.1639 REMARK 3 2 3.0358 - 2.4099 1.00 2874 128 0.1690 0.1748 REMARK 3 3 2.4099 - 2.1053 1.00 2880 142 0.1535 0.1699 REMARK 3 4 2.1053 - 1.9128 1.00 2842 137 0.1407 0.1494 REMARK 3 5 1.9128 - 1.7757 1.00 2830 156 0.1407 0.1556 REMARK 3 6 1.7757 - 1.6711 1.00 2823 143 0.1312 0.1364 REMARK 3 7 1.6711 - 1.5874 1.00 2843 124 0.1241 0.1440 REMARK 3 8 1.5874 - 1.5183 1.00 2862 134 0.1225 0.1259 REMARK 3 9 1.5183 - 1.4598 1.00 2852 139 0.1170 0.1251 REMARK 3 10 1.4598 - 1.4095 1.00 2811 156 0.1140 0.1409 REMARK 3 11 1.4095 - 1.3654 1.00 2789 155 0.1184 0.1362 REMARK 3 12 1.3654 - 1.3264 1.00 2804 154 0.1144 0.1361 REMARK 3 13 1.3264 - 1.2914 1.00 2825 156 0.1197 0.1536 REMARK 3 14 1.2914 - 1.2599 1.00 2829 149 0.1158 0.1630 REMARK 3 15 1.2599 - 1.2313 1.00 2828 136 0.1162 0.1091 REMARK 3 16 1.2313 - 1.2051 1.00 2799 119 0.1133 0.1400 REMARK 3 17 1.2051 - 1.1810 1.00 2844 135 0.1124 0.1311 REMARK 3 18 1.1810 - 1.1587 1.00 2816 145 0.1130 0.1427 REMARK 3 19 1.1587 - 1.1380 1.00 2797 134 0.1171 0.1450 REMARK 3 20 1.1380 - 1.1187 1.00 2865 144 0.1143 0.1273 REMARK 3 21 1.1187 - 1.1007 1.00 2770 153 0.1219 0.1304 REMARK 3 22 1.1007 - 1.0837 1.00 2793 161 0.1262 0.1456 REMARK 3 23 1.0837 - 1.0678 1.00 2820 143 0.1385 0.1407 REMARK 3 24 1.0678 - 1.0527 1.00 2811 157 0.1430 0.1617 REMARK 3 25 1.0527 - 1.0385 1.00 2795 149 0.1575 0.1833 REMARK 3 26 1.0385 - 1.0250 1.00 2829 135 0.1699 0.1795 REMARK 3 27 1.0250 - 1.0122 0.99 2773 126 0.1954 0.1786 REMARK 3 28 1.0122 - 1.0000 0.87 2472 107 0.2139 0.2332 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.070 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 13.640 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 10.74 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.14 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 1399 REMARK 3 ANGLE : 1.033 1916 REMARK 3 CHIRALITY : 0.089 220 REMARK 3 PLANARITY : 0.007 243 REMARK 3 DIHEDRAL : 19.369 512 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5DGJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-AUG-15. REMARK 100 THE DEPOSITION ID IS D_1000213174. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-APR-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.8 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 82788 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.000 REMARK 200 RESOLUTION RANGE LOW (A) : 34.210 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.04700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.02 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.20 REMARK 200 R MERGE FOR SHELL (I) : 0.47400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.5.7 REMARK 200 STARTING MODEL: 3UR9 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.59 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.94 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% V/V PENTAERYTHRITOL ETHOXYLATE REMARK 280 (15/4 EO/OH), 0.05 M BIS-TRIS, 0.05 M AMMONIUM SULFATE, PH 6.5, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 32.58450 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 20.58800 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 32.58450 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 20.58800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 421 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 428 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 GLY A 133 REMARK 465 THR A 134 REMARK 465 ILE A 135 REMARK 465 PRO A 136 REMARK 465 LYS A 162 REMARK 465 SER A 163 REMARK 465 GLY A 164 REMARK 465 GLY A 174 REMARK 465 GLU A 175 REMARK 465 GLY A 176 REMARK 465 GLU A 177 REMARK 465 THR A 178 REMARK 465 ALA A 179 REMARK 465 LEU A 180 REMARK 465 GLU A 181 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 108 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 112 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 113 CG CD1 CD2 REMARK 470 LEU A 132 CG CD1 CD2 REMARK 470 ASN A 149 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 344 O HOH A 422 2.11 REMARK 500 O HOH A 323 O HOH A 409 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 52 146.97 -170.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 V64 A 201 REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: TERT-BUTYL [(4S,7S,10S)-7-(CYCLOHEXYLMETHYL)-10- REMARK 630 (HYDROXYMETHYL)-5,8,13-TRIOXO-22-OXA-6,9,14,20,21- REMARK 630 PENTAAZABICYCLO[17.2.1]DOCOSA-1(21),19-DIEN-4-YL]CARBAMATE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 V64 A 201 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: BOC 5AR GAU ALC REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue V64 A 201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5DG6 RELATED DB: PDB DBREF 5DGJ A 1 181 UNP Q83883 POLG_NVN68 1101 1281 SEQADV 5DGJ MET A -6 UNP Q83883 EXPRESSION TAG SEQADV 5DGJ HIS A -5 UNP Q83883 EXPRESSION TAG SEQADV 5DGJ HIS A -4 UNP Q83883 EXPRESSION TAG SEQADV 5DGJ HIS A -3 UNP Q83883 EXPRESSION TAG SEQADV 5DGJ HIS A -2 UNP Q83883 EXPRESSION TAG SEQADV 5DGJ HIS A -1 UNP Q83883 EXPRESSION TAG SEQADV 5DGJ HIS A 0 UNP Q83883 EXPRESSION TAG SEQRES 1 A 188 MET HIS HIS HIS HIS HIS HIS ALA PRO PRO THR LEU TRP SEQRES 2 A 188 SER ARG VAL THR LYS PHE GLY SER GLY TRP GLY PHE TRP SEQRES 3 A 188 VAL SER PRO THR VAL PHE ILE THR THR THR HIS VAL VAL SEQRES 4 A 188 PRO THR GLY VAL LYS GLU PHE PHE GLY GLU PRO LEU SER SEQRES 5 A 188 SER ILE ALA ILE HIS GLN ALA GLY GLU PHE THR GLN PHE SEQRES 6 A 188 ARG PHE SER LYS LYS MET ARG PRO ASP LEU THR GLY MET SEQRES 7 A 188 VAL LEU GLU GLU GLY CYS PRO GLU GLY THR VAL CYS SER SEQRES 8 A 188 VAL LEU ILE LYS ARG ASP SER GLY GLU LEU LEU PRO LEU SEQRES 9 A 188 ALA VAL ARG MET GLY ALA ILE ALA SER MET ARG ILE GLN SEQRES 10 A 188 GLY ARG LEU VAL HIS GLY GLN SER GLY MET LEU LEU THR SEQRES 11 A 188 GLY ALA ASN ALA LYS GLY MET ASP LEU GLY THR ILE PRO SEQRES 12 A 188 GLY ASP CYS GLY ALA PRO TYR VAL HIS LYS ARG GLY ASN SEQRES 13 A 188 ASP TRP VAL VAL CYS GLY VAL HIS ALA ALA ALA THR LYS SEQRES 14 A 188 SER GLY ASN THR VAL VAL CYS ALA VAL GLN ALA GLY GLU SEQRES 15 A 188 GLY GLU THR ALA LEU GLU HET V64 A 201 34 HETNAM V64 TERT-BUTYL [(4S,7S,10S)-7-(CYCLOHEXYLMETHYL)-10- HETNAM 2 V64 (HYDROXYMETHYL)-5,8,13-TRIOXO-22-OXA-6,9,14,20,21- HETNAM 3 V64 PENTAAZABICYCLO[17.2.1]DOCOSA-1(21),19-DIEN-4- HETNAM 4 V64 YL]CARBAMATE FORMUL 2 V64 C29 H48 N6 O7 FORMUL 3 HOH *132(H2 O) HELIX 1 AA1 PRO A 2 SER A 7 1 6 HELIX 2 AA2 HIS A 30 VAL A 32 5 3 HELIX 3 AA3 THR A 123 ASN A 126 5 4 SHEET 1 AA1 5 VAL A 9 PHE A 12 0 SHEET 2 AA1 5 GLY A 15 TRP A 19 -1 O GLY A 15 N PHE A 12 SHEET 3 AA1 5 VAL A 24 THR A 28 -1 O ILE A 26 N PHE A 18 SHEET 4 AA1 5 PHE A 55 PHE A 60 -1 O PHE A 58 N PHE A 25 SHEET 5 AA1 5 ILE A 47 ALA A 52 -1 N ALA A 48 O ARG A 59 SHEET 1 AA2 2 GLU A 38 PHE A 39 0 SHEET 2 AA2 2 GLU A 42 PRO A 43 -1 O GLU A 42 N PHE A 39 SHEET 1 AA3 8 VAL A 72 LEU A 73 0 SHEET 2 AA3 8 ASP A 150 ALA A 160 1 O VAL A 153 N VAL A 72 SHEET 3 AA3 8 THR A 166 ALA A 170 -1 O ALA A 170 N VAL A 156 SHEET 4 AA3 8 ARG A 112 LEU A 121 -1 N GLY A 119 O VAL A 167 SHEET 5 AA3 8 LEU A 94 ILE A 109 -1 N GLY A 102 O SER A 118 SHEET 6 AA3 8 VAL A 82 LYS A 88 -1 N ILE A 87 O LEU A 95 SHEET 7 AA3 8 PRO A 142 ARG A 147 -1 O VAL A 144 N SER A 84 SHEET 8 AA3 8 ASP A 150 ALA A 160 -1 O ASP A 150 N ARG A 147 LINK SG ACYS A 139 C24 V64 A 201 1555 1555 1.81 LINK SG BCYS A 139 C24 V64 A 201 1555 1555 1.80 SITE 1 AC1 12 HIS A 30 GLU A 54 ILE A 109 GLN A 110 SITE 2 AC1 12 GLY A 137 ASP A 138 CYS A 139 HIS A 157 SITE 3 AC1 12 ALA A 158 ALA A 159 ALA A 160 HOH A 341 CRYST1 65.169 41.176 61.679 90.00 109.36 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015345 0.000000 0.005390 0.00000 SCALE2 0.000000 0.024286 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017184 0.00000